1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAudacious Goals Initiative (AGI) for Regenerative Medicine is sponsored by National Eye Institute (NEI), National Institutes of Health (NIH). An initiative aiming to restore vision through retinal regeneration, including projects targeting retinal ganglion cells.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Audacious Goals Initiative | National Eye Institute Audacious Goals Initiative Goal: Restore vision through regeneration of the retina The Audacious Goals Initiative (AGI) for Regenerative Medicine is an effort by the National Eye Institute (NEI) to push the boundaries of vision science and restore vision through regeneration of the retina.
By facilitating cross-disciplinary research, we are tackling the most devastating and difficult-to-treat eye diseases. Our audacious goal is to replace cells of the retina that have been damaged by disease or injury and to restore their connections to the visual centers of the brain.
Through strategic research funding, NEI is enlisting dynamic scientists and teams who are developing the necessary knowledge and technology to make this goal a reality. AGI research specifically targets the photoreceptors and retinal ganglion cells. Photoreceptors — often called rods and cones — are cells in the retina that, when stimulated by light, generate signals the brain perceives as images.
The retinal ganglion cells carry these signals from the photoreceptors to the brain. Learn more about the retina and our audacious goal Imaging tools, cell regeneration, and disease models The AGI is catalyzing research that will enable the restoration of vision through regeneration of the retina. Several research groups are developing new imaging tools to see the eye and optic nerve in unprecedented detail.
The researchers will use these tools to examine individual nerve cells. Six projects aim to identify biological factors that affect neural regeneration in the retina. Five multi-disciplinary teams are developing new disease models for a range of eye conditions.
Scientists can then use these disease models to develop new treatments. Learn more about NEI-funded AGI projects AGI history, planning, and guidance The AGI began in 2013 with a prize competition that challenged participants to imagine the greatest achievement for vision research during the next 10-15 years.
After reviewing more than 450 innovative proposals from around the world, NEI chose to pursue the goal of restoring vision through the regeneration of neurons and neural connections in the eye and visual system. The AGI Steering Committee plots the scientific trajectory of the AGI, identifying knowledge gaps and the scientific expertise needed to bridge them.
The National Advisory Eye Council (NAEC) provides administrative guidance, advising the NEI director on AGI funding plans and providing a second level of review for research funding proposals. The AGI Working Group helps draft funding announcements, monitors the progress of research programs, and makes recommendations to the AGI Steering Committee, the NAEC, and the NEI Director.
Learn more about AGI history and guidance For more information, email NEIAudaciousGoal@nih. gov . Last updated: October 21, 2025
According to the current listing, eligibility includes: Researchers and institutions engaged in regenerative medicine and vision restoration. Confirm the full requirements in the official notice before applying.
Audacious Goals Initiative (AGI) for Regenerative Medicine is funded by National Eye Institute (NEI), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article